Use of the Electronic Health Record for Monitoring Adverse Drug Reactions.

IF 5.4 2区医学 Q1 ALLERGY

Current Allergy and Asthma Reports Pub Date : 2023-07-01 DOI:10.1007/s11882-023-01087-w

Anum F Muzaffar, Sandra Abdul-Massih, James M Stevenson, Santiago Alvarez-Arango

{"title":"Use of the Electronic Health Record for Monitoring Adverse Drug Reactions.","authors":"Anum F Muzaffar, Sandra Abdul-Massih, James M Stevenson, Santiago Alvarez-Arango","doi":"10.1007/s11882-023-01087-w","DOIUrl":null,"url":null,"abstract":"Purpose of review: Adverse drug reactions (ADRs) are a significant cause of morbidity and mortality. The electronic health record (EHR) provides an opportunity to monitor ADRs, mainly through the utilization of drug allergy data and pharmacogenomics. This review article explores the current use of the EHR for ADR monitoring and highlights areas that require improvement.Recent findings: Recent research has identified several issues with using EHR for ADR monitoring. These include the lack of standardization between EHR systems, specificity in data entry options, incomplete and inaccurate documentation, and alert fatigue. These issues can limit the effectiveness of ADR monitoring and compromise patient safety. The EHR has great potential for monitoring ADR but needs significant updates to improve patient safety and optimize care. Future research should concentrate on developing standardized documentation and clinical decision support systems within EHRs. Healthcare professionals should also be educated on the significance of accurate and complete ADR monitoring.","PeriodicalId":55198,"journal":{"name":"Current Allergy and Asthma Reports","volume":"23 7","pages":"417-426"},"PeriodicalIF":5.4000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Allergy and Asthma Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11882-023-01087-w","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: Adverse drug reactions (ADRs) are a significant cause of morbidity and mortality. The electronic health record (EHR) provides an opportunity to monitor ADRs, mainly through the utilization of drug allergy data and pharmacogenomics. This review article explores the current use of the EHR for ADR monitoring and highlights areas that require improvement.

Recent findings: Recent research has identified several issues with using EHR for ADR monitoring. These include the lack of standardization between EHR systems, specificity in data entry options, incomplete and inaccurate documentation, and alert fatigue. These issues can limit the effectiveness of ADR monitoring and compromise patient safety. The EHR has great potential for monitoring ADR but needs significant updates to improve patient safety and optimize care. Future research should concentrate on developing standardized documentation and clinical decision support systems within EHRs. Healthcare professionals should also be educated on the significance of accurate and complete ADR monitoring.

Abstract Image

查看原文本刊更多论文

使用电子健康记录监测药物不良反应。

综述目的:药物不良反应(adr)是导致发病率和死亡率的重要原因。电子健康记录(EHR)提供了一个监测不良反应的机会，主要是通过利用药物过敏数据和药物基因组学。这篇综述文章探讨了电子病历用于ADR监测的当前使用情况，并强调了需要改进的领域。最近的发现:最近的研究已经确定了使用电子病历进行不良反应监测的几个问题。这些问题包括EHR系统之间缺乏标准化，数据输入选项的特殊性，不完整和不准确的文档以及警报疲劳。这些问题会限制不良反应监测的有效性并危及患者安全。电子病历在监测不良反应方面具有巨大潜力，但需要进行重大更新，以提高患者安全性并优化护理。未来的研究应集中在开发标准化的文件和临床决策支持系统的电子病历。医疗保健专业人员也应了解准确和完整的不良反应监测的重要性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Allergy and Asthma Reports 医学-过敏

CiteScore

11.20

自引率

1.80%

发文量

审稿时长

6-12 weeks

期刊介绍： The aim of Current Allergy and Asthma Reports is to systematically provide the views of highly selected experts on current advances in the fields of allergy and asthma and highlight the most important papers recently published. All reviews are intended to facilitate the understanding of new advances in science for better diagnosis, treatment, and prevention of allergy and asthma. We accomplish this aim by appointing international experts in major subject areas across the discipline to review select topics emphasizing recent developments and highlighting important new papers and emerging concepts. We also provide commentaries from well-known figures in the field, and an Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research. Over a one- to two-year period, readers are updated on all the major advances in allergy and asthma.